Wei Foong Lim
Direktor/Vorstandsmitglied bei BIONEXUS GENE LAB CORP.
Vermögen: 299 230 $ am 30.04.2024
Profil
Wei Foong Lim is currently the Director at Chemrex Corp.
Sdn.
Bhd.
He is also an Independent Non-Executive Director at EVD Bhd.
starting in 2024 and a Director at BioNexus Gene Lab Corp.
starting in 2023.
Mr. Lim completed his undergraduate degree at Western Michigan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIONEXUS GENE LAB CORP
2,84% | 16.04.2024 | 504 603 ( 2,84% ) | 299 230 $ | 30.04.2024 |
Aktive Positionen von Wei Foong Lim
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONEXUS GENE LAB CORP. | Direktor/Vorstandsmitglied | 11.12.2023 |
| EVD | Direktor/Vorstandsmitglied | 22.02.2024 |
Chemrex Corp. Sdn. Bhd.
 Chemrex Corp. Sdn. Bhd. Wholesale DistributorsDistribution Services Part of BioNexus Gene Lab Corp., Chemrex Corp. Sdn. The private company is based in Cheras, Malaysia. Bhd. is a Malaysian company that wholesales chemicals and resins. Chemrex Corp. Sdn. The CEO of the company is Chan Chong Wong. was acquired by BioNexus Gene Lab Corp. on December 31, 2020 for $133.14 million. | Direktor/Vorstandsmitglied | - |
Ausbildung von Wei Foong Lim
| Western Michigan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIONEXUS GENE LAB CORP. | Commercial Services |
| EVD | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Chemrex Corp. Sdn. Bhd.
Chemrex Corp. Sdn. Bhd. Wholesale DistributorsDistribution Services Part of BioNexus Gene Lab Corp., Chemrex Corp. Sdn. The private company is based in Cheras, Malaysia. Bhd. is a Malaysian company that wholesales chemicals and resins. Chemrex Corp. Sdn. The CEO of the company is Chan Chong Wong. was acquired by BioNexus Gene Lab Corp. on December 31, 2020 for $133.14 million. | Distribution Services |
